Deals
Quidel to Acquire Ortho Clinical Diagnostics for $6 Billion
This article is for subscribers only.
Quidel Corp. has agreed to purchase testing company Ortho Clinical Diagnostics Holdings for $6 billion with a combination for cash and newly issued shares.
Quidel will pay $24.68 a share, a 25% premium over Ortho Clinical’s closing price on Wednesday, the companies said in a statement Thursday.